Blood Transfusions in Patients with Advanced Cancer at the End-of-Life: Are They Really Beneficial?

IF 1.2 Q4 HEALTH CARE SCIENCES & SERVICES
Indian Journal of Palliative Care Pub Date : 2025-04-01 Epub Date: 2025-04-22 DOI:10.25259/IJPC_356_2024
Steven Callaghan, Kim Sadler, Gassan Adnan Abudari, Muneerah Almutairi, Salma Musaed Almusaed, Bayan Alqahtany, Nessreen Abu Alsamh, Ruth Evangelista, Fawad Ahmad, Mahmoud Yassein Sroor, Hassan Alkhudairi
{"title":"Blood Transfusions in Patients with Advanced Cancer at the End-of-Life: Are They Really Beneficial?","authors":"Steven Callaghan, Kim Sadler, Gassan Adnan Abudari, Muneerah Almutairi, Salma Musaed Almusaed, Bayan Alqahtany, Nessreen Abu Alsamh, Ruth Evangelista, Fawad Ahmad, Mahmoud Yassein Sroor, Hassan Alkhudairi","doi":"10.25259/IJPC_356_2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Anaemia is prevalent in individuals with advanced cancer and may contribute to adversely affecting their quality of life. In palliative care (PC), red blood cell (RBC) transfusions are regularly administered to address bothersome symptoms such as fatigue and dyspnoea. However, they are not without risks and adverse effects in individuals who are often frail at the end of life. Within this context, RBC transfusion benefits and drawbacks have yet to be demonstrated. This study aimed to assess RBCs transfusion-targeted indications, practices and clinical outcomes at the end-of-life in hospitalised patients with advanced malignancy.</p><p><strong>Materials and methods: </strong>A retrospective cohort design was used. All adults with a cancer diagnosis admitted to a PC Unit in a tertiary care centre in Saudi Arabia and who received at least one RBC transfusion between 1 January 2020 and 1 January 2024 were included in the study. Data were retrieved from their medical records (demographics, clinical and transfusion episode information) and included the <i>Charlson Comorbidity Index</i>.</p><p><strong>Results: </strong>A total of 84 patients were included, comprising a total of 159 episodes of transfusion. Patients had a mean age of 47 years (19.4%). The most frequent location of cancer was the gastrointestinal system (34.6%). For most patients, a low haemoglobin level was the main indication for the transfusion, without precise symptoms being targeted. There was no improvement following several transfusion episodes (82.4%). A moderate negative correlation was observed between age and survival days post-transfusion.</p><p><strong>Conclusion: </strong>There is a need for further studies to better understand the benefits of RBC transfusions at the end of life. In addition, more attention is warranted to establish targeted clinical outcomes pre-transfusion rather than relying on abnormal laboratory values. Validated self-reported tools should be used to ensure the benefits of an intervention that involves such a limited and valuable resource.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":"31 2","pages":"186-191"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12362034/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Palliative Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/IJPC_356_2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Anaemia is prevalent in individuals with advanced cancer and may contribute to adversely affecting their quality of life. In palliative care (PC), red blood cell (RBC) transfusions are regularly administered to address bothersome symptoms such as fatigue and dyspnoea. However, they are not without risks and adverse effects in individuals who are often frail at the end of life. Within this context, RBC transfusion benefits and drawbacks have yet to be demonstrated. This study aimed to assess RBCs transfusion-targeted indications, practices and clinical outcomes at the end-of-life in hospitalised patients with advanced malignancy.

Materials and methods: A retrospective cohort design was used. All adults with a cancer diagnosis admitted to a PC Unit in a tertiary care centre in Saudi Arabia and who received at least one RBC transfusion between 1 January 2020 and 1 January 2024 were included in the study. Data were retrieved from their medical records (demographics, clinical and transfusion episode information) and included the Charlson Comorbidity Index.

Results: A total of 84 patients were included, comprising a total of 159 episodes of transfusion. Patients had a mean age of 47 years (19.4%). The most frequent location of cancer was the gastrointestinal system (34.6%). For most patients, a low haemoglobin level was the main indication for the transfusion, without precise symptoms being targeted. There was no improvement following several transfusion episodes (82.4%). A moderate negative correlation was observed between age and survival days post-transfusion.

Conclusion: There is a need for further studies to better understand the benefits of RBC transfusions at the end of life. In addition, more attention is warranted to establish targeted clinical outcomes pre-transfusion rather than relying on abnormal laboratory values. Validated self-reported tools should be used to ensure the benefits of an intervention that involves such a limited and valuable resource.

Abstract Image

Abstract Image

Abstract Image

晚期癌症患者在生命末期输血真的有益吗?
目的:贫血在晚期癌症患者中普遍存在,并可能对其生活质量产生不利影响。在姑息治疗(PC)中,经常进行红细胞(RBC)输注,以解决疲劳和呼吸困难等令人烦恼的症状。然而,对于那些在生命结束时往往身体虚弱的人来说,它们并非没有风险和不利影响。在这种情况下,红细胞输血的好处和缺点尚未得到证实。本研究旨在评估晚期恶性肿瘤住院患者生命末期输注红细胞的适应症、做法和临床结果。材料和方法:采用回顾性队列设计。所有在沙特阿拉伯三级保健中心PC单元接受癌症诊断并在2020年1月1日至2024年1月1日期间至少接受过一次RBC输血的成年人都被纳入该研究。数据从他们的医疗记录(人口统计、临床和输血事件信息)中检索,并包括Charlson合并症指数。结果:共纳入84例患者,共159次输血。患者平均年龄47岁(19.4%)。最常见的癌症部位是胃肠道(34.6%)。对于大多数患者,低血红蛋白水平是输血的主要指征,没有明确的症状。几次输血后无改善(82.4%)。年龄与输血后存活天数之间存在中度负相关。结论:需要进一步的研究来更好地了解生命末期输血的益处。此外,需要更多地关注输血前建立有针对性的临床结果,而不是依赖异常的实验室值。应使用经过验证的自我报告工具,以确保涉及如此有限和宝贵资源的干预措施的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Indian Journal of Palliative Care
Indian Journal of Palliative Care HEALTH CARE SCIENCES & SERVICES-
CiteScore
2.30
自引率
0.00%
发文量
57
期刊介绍: Welcome to the website of the Indian Journal of Palliative Care. You have free full text access to recent issues of the journal. The links connect you to •guidelines and systematic reviews in palliative care and oncology •a directory of palliative care programmes in India and IAPC membership •Palliative Care Formulary, book reviews and other educational material •guidance on statistical tests and medical writing.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信